Genotyping study of Scedosporium apiospermum isolates from patients with cystic fibrosis

被引:72
作者
Defontaine, A
Zouhair, R
Cimon, B
Carrère, J
Bailly, E
Symoens, F
Diouri, M
Hallet, JN
Bouchara, JP
机构
[1] CNRS, FRE 2230, Fac Sci, Lab Biotechnol,Unite Biocatalyse, F-44072 Nantes 03, France
[2] Ctr Hosp Univ, Lab Parasitol Mycol, UPRES EA 3142, Grp Etud Interact Hote Parasite, Angers, France
[3] Hop Renee Sabran, Biol Lab, Giens, France
[4] Ctr Hosp Univ, Serv Parasitol Mycol, Tours, France
[5] Inst Sci Sante Publ Louis Pasteur, Sect Mycol, Brussels, Belgium
[6] Univ Moulay Ismail, Fac Sci, Dept Biol, Meknes, Morocco
关键词
D O I
10.1128/JCM.40.6.2108-2114.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Usually a saprophyte, Scedosporium apiospermum often colonizes the respiratory tracts of patients with cystic fibrosis (CF). In order to improve our understanding of the molecular epidemiology of the airway colonization, 129 sequential and multiple isolates collected from January 1998 to March 1999 from nine CF patients monitored in three hospitals in France were typed by random amplification of polymorphic DNA with primers GC70, UBC-701, and UBC-703. Among these primers, UBC-703 was the most discriminating, allowing the differentiation of 14 genotypes. Combining the results obtained with this three-primer set resulted in the differentiation of 16 genotypes. No common genotype was found among the different patients, and no clustering according to geographic origin of the isolates was seen. In addition, five of the patients were colonized by a single genotype. The others usually exhibited a predominant genotype accompanied by one or two others, which were found occasionally and were genetically close to the predominant genotype. Thus, our study demonstrates the persistence of the fungus despite antifungal treatments and therefore reinforces the need for the development of new antifungals that are more efficient against this species.
引用
收藏
页码:2108 / 2114
页数:7
相关论文
共 26 条
  • [1] [Anonymous], 1994, AEROBIOLOGIA, DOI DOI 10.1007/BF02459231
  • [2] Cimon B, 1995, J MYCOL MED, V5, P211
  • [3] Molecular epidemiology of airway colonisation by Aspergillus fumigatus in cystic fibrosis patients
    Cimon, B
    Symoens, F
    Zouhair, R
    Chabasse, D
    Nolard, N
    Defontaine, A
    Bouchara, JP
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 2001, 50 (04) : 367 - 374
  • [4] Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis
    Cimon, B
    Carrère, J
    Vinatier, JF
    Chazalette, JP
    Chabasse, D
    Bouchara, JP
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2000, 19 (01) : 53 - 56
  • [5] Cremer G, 1996, J MYCOL MED, V6, P165
  • [6] DUPONT B, 1991, Journal de Mycologie Medicale, V1, P33
  • [7] In vitro susceptibilities to amphotericin B, itraconazole, and miconazole of filamentous fungi isolated from patients with cystic fibrosis
    Hennequin, C
    Benailly, N
    Silly, C
    Sorin, M
    Scheinmann, P
    Lenoir, G
    Gaillard, JL
    Berche, P
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (09) : 2064 - 2066
  • [8] Issakainen J, 1997, J MED VET MYCOL, V35, P389
  • [9] PATHOGENESIS OF CYSTIC-FIBROSIS
    KOCH, C
    HOIBY, N
    [J]. LANCET, 1993, 341 (8852) : 1065 - 1069
  • [10] RIBOSOMAL DNA INTERNAL TRANSCRIBED SPACER ANALYSIS SUPPORTS SYNONOMY OF SCEDOSPORIUM-INFLATUM AND LOMENTOSPORA PROLIFICANS
    LENNON, PA
    COOPER, CR
    SALKIN, IF
    LEE, SB
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (10) : 2413 - 2416